-+ 0.00%
-+ 0.00%
-+ 0.00%

United States Antimony (UAMY) Pulls Full Year Guidance After 10% Q3 Revenue Gain

Simply Wall St·11/14/2026 08:33:36
Listen to the news
  • United States Antimony (NYSE:UAMY) reported Q3 antimony revenue that was 10% higher, supported by stronger sales volumes.
  • The business missed analyst forecasts for the quarter, despite the reported improvement in top-line antimony sales.
  • Management withdrew previously issued full-year revenue guidance and disclosed expanded government payment authorizations tied to its Defense Logistics Agency contract.
  • The combination of Q3 sales growth, guidance withdrawal and larger Defense Logistics Agency support sits against a broader picture our research has built. Check out 2 other big wins that United States Antimony investors should know about.

This stock is far from the only way to get exposure to critical metals demand, so it is worth scanning 33 best rare earth metal stocks.

NYSE:UAMY Earnings & Revenue Growth as at Nov 2026
NYSE:UAMY Earnings & Revenue Growth as at Nov 2026

United States Antimony operates in the Metals and Mining industry, producing and selling antimony, zeolite, and precious metals across the US and Canada, so any shift in government support or contract structure directly influences how its core products reach industrial and defense customers.

We've flagged 2 risks for United States Antimony. See which could impact your investment.

How can United States Antimony grow antimony volumes yet still report a larger loss?

Q3 sales reached US$10.13 million compared with US$8.7 million a year earlier, helped by higher antimony volumes, including DLA related shipments. The net loss still widened to US$9.53 million from US$4.78 million as costs and expenses outpaced the extra revenue. For the nine month period, weaker sales and larger losses underline how sensitive the business is to pricing and overheads.

Does this change the United States Antimony Narrative or just stress its execution risks?

The Narrative already flags that volume alone is not enough and that rising operating costs could keep earnings under pressure. With Q3 showing a bigger loss despite DLA supported volume and management pulling full year revenue guidance, this update leans into that concern about cost inflation and delivery timing on major contracts.

See how these catalysts shape United States Antimony's path to a $10.92 fair value.

What should investors watch next after the guidance withdrawal?

Attention now concentrates on how quickly United States Antimony converts its US$245 million DLA contract into invoiced revenue and cash. The next key signposts are quarterly disclosures on pounds shipped and recognized under that agreement, alongside whether net loss narrows from the US$9.53 million level reported for Q3 2026.

The valuation gut check many United States Antimony buyers skip

Before acting on any headline, a careful buyer usually wants to know what the stream of future cash coming out of United States Antimony suggests the whole enterprise might be worth next to today’s share price. Find out exactly what United States Antimony is worth today based on its cash flows.